Table of contents
Volume 89, Issue 1
Published online 1 July 2003 (1-222)
Minireviews |
Clinical |
Epidemiology |
Molecular and Cellular Pathology |
Experimental Therapeutics |
Corrigendum
Editorial
The NHS breast cancer screening programme FREE
N E Day
Br J Cancer 89: 1; doi:10.1038/sj.bjc.6601129
Minireviews
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer FREE
C P S Potter and A L Harris
Br J Cancer 89: 2-7; doi:10.1038/sj.bjc.6600936
Surrogate markers in antiangiogenesis clinical trials FREE
D W Davis, D J McConkey, J L Abbruzzese and R S Herbst
Br J Cancer 89: 8-14; doi:10.1038/sj.bjc.6601035
Clinical
Breast cancer teams: the impact of constitution, new cancer workload, and methods of operation on their effectiveness FREE
R Haward, Z Amir, C Borrill, J Dawson, J Scully, M West and R Sainsbury
Br J Cancer 89: 15-22; doi:10.1038/sj.bjc.6601073
Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a case–control study FREE
M Nakajima, H Saito, Y Soma, T Sobue, M Tanaka and A Munakata
Br J Cancer 89: 23-28; doi:10.1038/sj.bjc.6601002
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial FREE
C Bokemeyer, N Schleucher, B Metzner, M Thomas, O Rick, H-J Schmoll, C Kollmannsberger, I Boehlke, L Kanz and J T Hartmann
Br J Cancer 89: 29-35; doi:10.1038/sj.bjc.6600999
Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy? FREE
I Chau, R Jones, D Cunningham, A Wotherspoon, N Maisey, A R Norman, P Jain, L Bishop, A Horwich and D Catovsky
Br J Cancer 89: 36-42; doi:10.1038/sj.bjc.6601006
Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study FREE
H E Innes, D B Smith, S M O'Reilly, P I Clark, V Kelly and E Marshall
Br J Cancer 89: 43-49; doi:10.1038/sj.bjc.6600993
Rapid deterioration in quality of life during interleukin-2- and 
-interferon-based home therapy of renal cell carcinoma is associated with a good outcome FREE
J Atzpodien, Th Küchler, T Wandert and M Reitz
Br J Cancer 89: 50-54; doi:10.1038/sj.bjc.6600996
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis FREE
B Martin, M Paesmans, T Berghmans, F Branle, L Ghisdal, C Mascaux, A-P Meert, E Steels, F Vallot, J-M Verdebout, J-J Lafitte and J-P Sculier
Br J Cancer 89: 55-64; doi:10.1038/sj.bjc.6601095
Epidemiology
Survival of cervix cancer patients in Kampala, Uganda: 1995–1997 FREE
H Wabinga, A V Ramanakumar, C Banura, A Luwaga, S Nambooze and D M Parkin
Br J Cancer 89: 65-69; doi:10.1038/sj.bjc.6601034
Latest trends in cancer incidence among UK South Asians in Leicester FREE
L K Smith, J L Botha, A Benghiat and W P Steward
Br J Cancer 89: 70-73; doi:10.1038/sj.bjc.6600973
Up-to-date estimates of long-term cancer survival in England and Wales FREE
L K Smith, P C Lambert and D R Jones
Br J Cancer 89: 74-76; doi:10.1038/sj.bjc.6600976
Impact of NHS breast screening on advanced disease and mortality from breast cancer in the North West of England FREE
A G Threlfall, S Collins and C B J Woodman
Br J Cancer 89: 77-80; doi:10.1038/sj.bjc.6600842
Associations of adult measures of childhood growth with breast cancer: findings from the British Women's Heart and Health Study FREE
D A Lawlor, M Okasha, D Gunnell, G Davey Smith and S Ebrahim
Br J Cancer 89: 81-87; doi:10.1038/sj.bjc.6600972
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories FREE
P Sasieni, J Adams and J Cuzick
Br J Cancer 89: 88-93; doi:10.1038/sj.bjc.6600974
Risk of cancer in persons with AIDS in Italy, 1985–1998 FREE
L Dal Maso, S Franceschi, J Polesel, C Braga, P Piselli, E Crocetti, F Falcini, S Guzzinati, R Zanetti, M Vercelli and G Rezza for the Cancer and AIDS Registry Linkage Study
Br J Cancer 89: 94-100; doi:10.1038/sj.bjc.6601017
Molecular and Cellular Pathology
Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis FREE
G M Clifford, J S Smith, T Aguado and S Franceschi
Br J Cancer 89: 101-105; doi:10.1038/sj.bjc.6601024
The use of Raman spectroscopy to identify and grade prostatic adenocarcinoma in vitro FREE
P Crow, N Stone, C A Kendall, J S Uff, J A M Farmer, H Barr and M P J Wright
Br J Cancer 89: 106-108; doi:10.1038/sj.bjc.6601059
Clinical and economic benefit of HPV-load testing in follow-up and management of women postcone biopsy for CIN2–3 FREE
B Almog, R Gamzu, J Bornstein, I Levin, O Fainaru, J Niv, J B Lessing and A Bar-Am
Br J Cancer 89: 109-112; doi:10.1038/sj.bjc.6601032
Epstein–Barr virus gene expression in human breast cancer: protagonist or passenger? FREE
S A Xue, I A Lampert, J S Haldane, J E Bridger and B E Griffin
Br J Cancer 89: 113-119; doi:10.1038/sj.bjc.6601027
ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells FREE
M Mousli, R Hopfner, A-Q Abbady, D Monté, M Jeanblanc, P Oudet, B Louis and C Bronner
Br J Cancer 89: 120-127; doi:10.1038/sj.bjc.6601068
Proliferation and aneusomy predict survival of young patients with astrocytoma grade II FREE
P H Wessels, A H N Hopman, B Kubat, A G H Kessels, E W Hoving, M I J Ummelen, F C S Ramaekers and A Twijnstra
Br J Cancer 89: 128-134; doi:10.1038/sj.bjc.6601067
Expression of endogenous granzyme B in a subset of human primary breast carcinomas FREE
S X Hu, S Wang, J P Wang, G B Mills, Y Zhou and H-J Xu
Br J Cancer 89: 135-139; doi:10.1038/sj.bjc.6601051
FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma FREE
T Miyazaki, H Kato, M Nakajima, M Sohda, Y Fukai, N Masuda, R Manda, M Fukuchi, K Tsukada and H Kuwano
Br J Cancer 89: 140-145; doi:10.1038/sj.bjc.6601050
RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma FREE
R-Y Shyu, S-Y Jiang, J-M Chou, Y-L Shih, M-S Lee, J-C Yu, P-C Chao, Y-J Hsu and S-W Jao
Br J Cancer 89: 146-151; doi:10.1038/sj.bjc.6601049
No major tumorigenic role for 
-catenin in serrated as opposed to conventional colorectal adenomas FREE
T Yamamoto, K Konishi, T Yamochi, R Makino, K Kaneko, T Shimamura, H Ota and K Mitamura
Br J Cancer 89: 152-157; doi:10.1038/sj.bjc.6601070
Clinical significance of transmembrane 4 superfamily in colon cancer FREE
H Hashida, A Takabayashi, T Tokuhara, N Hattori, T Taki, H Hasegawa, S Satoh, N Kobayashi, Y Yamaoka and M Miyake
Br J Cancer 89: 158-167; doi:10.1038/sj.bjc.6601015
Experimental Therapeutics
Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines FREE
P Fustier, L Le Corre, N Chalabi, C Vissac-Sabatier, Y Communal, Y-J Bignon and D J Bernard-Gallon
Br J Cancer 89: 168-172; doi:10.1038/sj.bjc.6600983
Mechanistic studies on 
-aminolevulinic acid uptake and efflux in a mammary adenocarcinoma cell line FREE
S Correa García, A Casas, C Perotti, A Batlle and M Bermúdez Moretti
Br J Cancer 89: 173-177; doi:10.1038/sj.bjc.6601066
Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival FREE
O Fromigue, N Kheddoumi and J-J Body
Br J Cancer 89: 178-184; doi:10.1038/sj.bjc.6601009
Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells FREE
W Jin, L Wu, K Liang, B Liu, Y Lu and Z Fan
Br J Cancer 89: 185-191; doi:10.1038/sj.bjc.6601048
Inhibition of growth and induction of apoptosis in human breast cancer by transfection of gef gene FREE
H Boulaiz, J Prados, C Melguizo, Á M García, J A Marchal, J L Ramos, E Carrillo, C Vélez and A Aránega
Br J Cancer 89: 192-198; doi:10.1038/sj.bjc.6601064
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse FREE
A Scardino, P Correale, H Firat, M Pellegrini, K Kosmatopoulos, P Opolon, P Alves, R Zurbriggen, R Glück, F A Lemonnier, G Francini and M G Cusi
Br J Cancer 89: 199-205; doi:10.1038/sj.bjc.6601028
Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy FREE
S Bouralexis, D M Findlay, G J Atkins, A Labrinidis, S Hay and A Evdokiou
Br J Cancer 89: 206-214; doi:10.1038/sj.bjc.6601021
Carboxymethyl benzylamide dextran inhibits angiogenesis and growth of VEGF-overexpressing human epidermoid carcinoma xenograft in nude mice FREE
Y Hamma-Kourbali, A Starzec, R Vassy, A Martin, M Kraemer, G Perret and M Crépin
Br J Cancer 89: 215-221; doi:10.1038/sj.bjc.6601029
Corrigendum
Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures FREE
R Philip, E Campbell and D N Wheatley
Br J Cancer 89: 222; doi:10.1038/sj.bjc.6601096
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
